The phase 3 TAISHAN-302 trial found that tambotatug pelitecan (Tam-Peli, YL201), a novel anti-B7-H3 antibody-drug conjugate, ...

Results from the randomized Phase III ARTEMIS-008 trial show that risvutatug rezetecan (Ris-Rez), a B7-H3-directed ...

Results from the international phase 3 SWOG S1827 MAVERICK trial show that brain MRI surveillance alone improved cognitive ...

Treating inherited diseases is one of the greatest challenges in modern medicine. In the future, targeted gene corrections at ...

Laser blended vision is a treatment for presbyopia, the natural deterioration of our ability to see things close up that ...

Ivonescimab significantly prolonged overall survival compared with pembrolizumab as first-line treatment for patients with PD ...

A study led by the Barcelona Institute for Global Health (ISGlobal) and Aarhus University shows that children and adolescents ...

Researchers at Texas A&M University's Naresh K. Vashisht College of Medicine have identified time-specific patterns of brain ...

Cystic fibrosis, one of the most common genetic diseases in Switzerland, promotes chronic bacterial infections by impairing ...

Subcutaneous administration of tarlatamab was well tolerated and demonstrated preliminary antitumor activity in patients with ...

Extended-interval dosing regimens of tarlatamab demonstrated efficacy, safety and pharmacokinetic profiles generally ...

A new study published in The American Journal of Pathology provides new evidence that immune cells enter the retina via the ...